From functional studies in a tumor model, we concluded that CD4+ T cell help confers upon CTLs the exact properties desired for effective anti-tumor immunity, as defined by Chen and Mellman in “The cancer immunity cycle” (31). The gene discussed is CD4; the disease is cancer.